載入...
Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
BACKGROUND: Cardiotoxicity is an adverse effect of trastuzumab (TRA) in the treatment of human epidermal growth factor 2 positive (HER2+) breast cancer. Current literature on the cardioprotective effects of agents targeted against the renin-angiotensin-aldosterone system (RAAS) and beta-blockers (BB...
Na minha lista:
| 發表在: | Cardiooncology |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7048102/ https://ncbi.nlm.nih.gov/pubmed/32154015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40959-019-0043-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|